申请人:Bravi Gianpaolo
公开号:US20050043390A1
公开(公告)日:2005-02-24
Novel anti-viral agents of Formula
wherein:
A represents OR
1
, NR
1
R
2
, or R
1
wherein R
1
and R
2
are hydrogen, C
1-6
alkyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; or R
1
and R
2
together with the nitrogen atom to which they are attached form a 5 or 6 membered saturated cyclic group;
B represents C(O)R
3
wherein R
3
is C
1-6
alkyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl;
C represents C
1-6
alkyl, aryl, heteroaryl or heterocyclyl; D represents a saturated or unsaturated optionally substituted 6-membered heterocyclic ring;
E represents hydrogen or C
1-6
-alkyl;
F represents hydrogen, C
1-6
alkyl, aryl or heteroaryl; and
G represents hydrogen, C
1-6
alkyl, heterocyclylalkyl, arylalkyl or heteroarylalkyl; and salts, solvates and esters thereof, processes for their preparation and methods of using them in HCV treatment are provided.
本发明提供了Formula中的新型抗病毒剂,其中:A代表OR1,NR1R2或R1,其中R1和R2为氢,C1-6烷基,芳基,杂环芳基,芳基烷基或杂环芳基烷基;或者R1和R2与它们所附着的氮原子一起形成一个5或6个成员的饱和环;B代表C(O)R3,其中R3为C1-6烷基,芳基,杂环芳基,芳基烷基或杂环芳基烷基;C代表C1-6烷基,芳基,杂环芳基或杂环基;D代表饱和或不饱和的可选取代的6成员杂环环;E代表氢或C1-6烷基;F代表氢,C1-6烷基,芳基或杂环芳基;G代表氢,C1-6烷基,杂环基烷基,芳基烷基或杂环芳基烷基;以及它们的盐,溶剂合物和酯,提供了它们的制备方法和在HCV治疗中使用的方法。